Penggunaan Kontrasepsi pada Perempuan dengan HIV di Dunia

Dayu Marista; Ira Nurmala

doi:10.14710/jpki.17.1.25-34

DOI: https://doi.org/10.14710/jpki.17.1.25-34

Penggunaan Kontrasepsi pada Perempuan dengan HIV di Dunia

*Dayu Marista - Fakultas Kesehatan Masyarakat, Universitas Airlangga, Indonesia

Ira Nurmala - Fakultas Kesehatan Masyarakat, Universitas Airlangga, Indonesia

BibTex Citation Data :

@article{JPKI37909,
    author = {Dayu Marista and Ira Nurmala},
    title = {Penggunaan Kontrasepsi pada Perempuan dengan HIV di Dunia},
    journal = {Jurnal Promosi Kesehatan Indonesia},
  volume = {17},
    number = {1},
    year = {2022},
    keywords = {contraceptive use;HIV women;injections;good health;well being},
    abstract = {   Background:    HIV infection is a public health problem. In 2019, more than 38 million people were living with HIV, and more than 1.7 million people contracted HIV. On the other hand, it was reported that infant morbidity and mortality remained high, with more than 160,000 infants contracting HIV and more than 100,000 dying from AIDS-related causes. Increased access and improved service programs to control HIV transmission from mother to child are in line with the increasing number of pregnant women with HIV. Women with HIV and their partners need to plan carefully before deciding to have children. Women living with HIV and their partners need to take advantage of services that provide information and contraceptive tools to prevent unplanned pregnancies. The study aimed to understand how HIV-infected women chose contraceptives.     Method:    Search for articles with a systematic review using four databases consisting of Pubmed, Science Direct, Sage, and Emerald Insight with a publication range of 2017-2020. The keywords used were contraceptive use AND HIV women. The inclusion criteria used were women with HIV aged 15-49 years and used a cross-sectional design.     Results:    The findings indicated that injections, condoms, and implants were the most common methods of contraception used by women with HIV. Motivation for contraceptive use in women with HIV is influenced by age, marital status, knowledge, number of children, education, previous history of contraceptive use, history of childbirth, lack of fertility desires, income, residence, CD4 count, child's HIV status and partner's HIV status.          },
   issn = {2620-4053},   pages = {25--34}  doi = {10.14710/jpki.17.1.25-34},
    url = {https://ejournal.undip.ac.id/index.php/jpki/article/view/37909}
}

Citation Format:

Abstract

Background: HIV infection is a public health problem. In 2019, more than 38 million people were living with HIV, and more than 1.7 million people contracted HIV. On the other hand, it was reported that infant morbidity and mortality remained high, with more than 160,000 infants contracting HIV and more than 100,000 dying from AIDS-related causes. Increased access and improved service programs to control HIV transmission from mother to child are in line with the increasing number of pregnant women with HIV. Women with HIV and their partners need to plan carefully before deciding to have children. Women living with HIV and their partners need to take advantage of services that provide information and contraceptive tools to prevent unplanned pregnancies. The study aimed to understand how HIV-infected women chose contraceptives.

Method: Search for articles with a systematic review using four databases consisting of Pubmed, Science Direct, Sage, and Emerald Insight with a publication range of 2017-2020. The keywords used were contraceptive use AND HIV women. The inclusion criteria used were women with HIV aged 15-49 years and used a cross-sectional design.

Results: The findings indicated that injections, condoms, and implants were the most common methods of contraception used by women with HIV. Motivation for contraceptive use in women with HIV is influenced by age, marital status, knowledge, number of children, education, previous history of contraceptive use, history of childbirth, lack of fertility desires, income, residence, CD4 count, child's HIV status and partner's HIV status.

Fulltext View|Download

Keywords: contraceptive use;HIV women;injections;good health;well being

Article Metrics:

Article Info

Section: Research Article

Language : ID

In Volume 17 No.1 Januari 2022

Recent articles

Pengaruh Penggunaan Aplikasi Wellingbom 2.0 terhadap Kemampuan Suami Mendeteksi Dini Kehamilan Risiko Tinggi Penggunaan Kontrasepsi pada Perempuan dengan HIV di Dunia Keterpaparan Program GenRe (Generasi Berencana) dan Perilaku Pacaran Remaja Jawa Timur, Indonesia More recent articles

Most cited articles

Analisis Faktor-Faktor yang Berpengaruh Terhadap Kemauan Masyarakat Menjadi Peserta JPKM Mandiri di Wilayah Kota Salatiga Non Disclosure Of HIV Positive Status Of Women To Their Partner : Implication For PMTCT Faktor-Faktor Yang Berhubungan Dengan Praktik Wanita Pekerja Seks (WPS) Jalanan Dalam Upaya Pencegahan IMS Dan HIV/AIDS Di Sekitar Alun-Alun Dan Candi Prambanan Kabupaten Klaten Stakeholder Pemerintah Sebagai Prime Mover Keberhasilan Jejaring Pelayanan Kesehatan Peduli Remaja Analisis Faktor yang Berpengaruh dalam Swamedikasi Antibiotik pada Ibu Rumah Tangga di Kelurahan Kajen Kebupaten Pekalongan More cited articles

WHO. HIV Prevention, Infant Diagnosis, Antiretroviral Initiation and Monitoring. 2021
WHO. Prevention of Mother to Child Transmission (PMTCT). Situation and Trends. [Internet]. [cited 2021 Apr 10]. Available from: https://www.who.int/gho/hiv/epidemic_response/PMTCT/en/
WHO. PMTCT Strategic Vision 2010-2015. Preventing moother to child transmission of HIV to reach the UNGASS and Millennium Development Goals. Geneva, Switzerland: WHO; 2010
Kemenkes RI. Info Datin : Situasi Penyakit HIV/AIDS di Indonesia. Jakarta Selatan: Kementerian Kesehatan RI; 2016
Jeremia D, George J, Martin E, Temba B, Msuya S. Prevalence and factors influencing modern contraceptive use among HIV-positive women in Kilimanjaro region, northern Tanzania. Contracept Reprod Med. 2018 May 22;3:7
Kemenkes RI. Pedoman Manajemen Program Pencegahan Penularan HIV dan Sifilis dari Ibu ke Anak. Jakarta: Kementerian Kesehatan RI; 2015
WHO. Women and Adolescent Girls Living with HIV Need Better Advice and Access to Contraceptives [Internet]. 2019 [cited 2021 Apr 10]. Available from: https://www.who.int/hiv/mediacentre/news/contraceptive-for-women-girl-living-with-hiv/en/#:~:text=The%20recently%20updated%20August%202019,%2C%20and%20intrauterine%20devices%20(IUDs)
Adedimeji A, Abboud N, Merdekios B, Shiferaw M. A Qualitative Study of Barriers to Effectiveness of Interventions to Prevent Mother-to-Child Transmission of HIV in Arba Minch, Ethiopia. Int J Popul Res. 2012 Jul 8;2012
Kebede YB, Geremew TT, Mehretie Y, Abejie AN, Bewket L, Dellie E. Associated factors of modern contraceptive use among women infected with human immunodeficiency virus in Enemay District, Northwest Ethiopia : a facility-based cross-sectional study. BMC Publich Health. 2019;19(1)
Tewabe T, Ayalew T, Abdanur A, Jenbere D, Ayehu M, Talema G. Contraceptive use and associated factors among sexually active HIV positive women attending ART clinic in FHRH in Bahir Dar, north west, Ethiopia, 2018. Facility based cross-sectional study. 2019
Aradom H, Sendo E, Teshome G, Dinegde N, Gezahegn T. Factors associated with modern family planning use among women living with HIV who attended care and treatment clinics in Jigjiga town, Eastern Ethiopia. Ther Adv Reprod Health. 2020 Dec 13;14:263349412097696
Feyissa TR, Harris M, Forder P, Loxton D. Contraceptive use among sexually active women living with HIV in western Ethiopia. PLOS ONE. 2020 Aug 6;15:e0237212
Alene KA, Atalell KA. Contraceptive use and method preference among HIV-positive women in Amhara region, Ethiopia. BMC Womens Health. 2018 Jun 18;18(1):97
Tote KM, Raziano VT, Wall K, Cordes S, Ofotokun I, Haddad L. Contraceptive method use among HIV-positive women in a US urban outpatient clinic: An exploratory cross-sectional study. Contraception. 2018 Aug 1;98
Araya BM, Solomon A, Gebreslasie K, Gudayu T, Anteneh K. The role of counseling on modern contraceptive utilization among HIV positive women: The case of Northwest Ethiopia. BMC Womens Health. 2018 Jul 4;18
Dugg P, Chhabra P, Sharma A. Contraceptive use and unmet need for family planning among HIV-positive women: A hospital-based study. Indian J Public Health. 2020 Jan 1;64:32
Bongomin F, Eriatu A, Onen B, Cheputyo P, Godmercy S, Ekuk E, et al. Prevalence and Factors Associated with Contraceptive Use among HIV-Infected Women of Reproductive Age Attending Infectious Disease Clinic at Gulu Regional Referral Hospital, Northern Uganda. BioMed Res Int. 2018 Jun 10;2018
Towriss C, Phillips T, Brittain K, Zerbe A, Abrams E, Myer L. The injection or the injection? Restricted contraceptive choices among women living with HIV. Sex Reprod Health Matters. 2019 Dec 1;27:1628593
Yaya I, Patassi A, Landoh D, Bignandi E, Kolani K, Namoro A-D, et al. Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: A cross-sectional study. BMJ Open. 2018 Apr 1;8:e019006
Nasrullah M, Oraka E, Chavez P, Johnson C, Dinenno E. Factors Associated With Condom Use Among Sexually Active US Adults, National Survey of Family Growth, 2006–2010 and 2011–2013. J Sex Med. 2017 Apr 1;14:541–50
Brown A, Harries J, Cooper D, Morroni C. Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders. BMC Public Health. 2019 Jul 26;19(1):1003
Pyra M, Heffron R, Mugo NR, Nanda K, Thomas KK, Celum C, et al. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS Lond Engl. 2015 Nov;29(17):2353–9
Haddad LB, Polis CB, Sheth AN, Brown J, Kourtis AP, King C, et al. Contraceptive methods and risk of HIV acquisition or female-to-male transmission. Curr HIV/AIDS Rep. 2014 Dec;11(4):447–58
Harahap RA. Pengaruh Faktor Predisposing, Enabling dan Reinforcing Terhadap Pemberian Imunisasi Hepatitis B Pada Bayi di Puskesmas Bagan Batu Kecamatan Bagan Sinembah Kabupaten Rokan Hilir. J Jumantik. 2016;1(1)

Last update:

No citation recorded.

Last update: 2025-09-12 22:28:33

No citation recorded.

Authors still retain significant all copy rights to use and share their own published articles. Jurnal Promosi Kesehatan Indonesia and Universitas Diponegoro supports the need for authors to share, disseminate and maximize the impact of their research and these rights, in any databases.

As a journal Author, you have all copy rights for a large range of uses of your article, including use by your employing institute or company. These Author copy rights can be exercised without the need to obtain specific permission. Authors who publishing in JPKI have wide copy rights to use their works for teaching and scholarly purposes without needing to seek permission, including, but not limited to:

use for classroom teaching by Author or Author's institution and presentation at a meeting or conference and distributing copies to attendees;
use for internal training by author's company;
distribution to colleagues for their research use;
use in a subsequent compilation of the author's works;
inclusion in a thesis or dissertation;
reuse of portions or extracts from the article in other works (with full acknowledgement of final article);
preparation of derivative works (other than commercial purposes) (with full acknowledgement of final article);
voluntary posting on open web sites operated by author or author’s institution for scholarly purposes,

(but it should follow the open access license of Creative Common CC-by-SA License).

Authors/Readers/Third Parties can copy and redistribute the material in any medium or format, as well as remix, transform, and build upon the material for any purpose, even commercially, but they must give appropriate credit (the name of the creator and attribution parties (authors detail information), a copyright notice, an open access license notice, a disclaimer notice, and a link to the material), provide a link to the license, and indicate if changes were made.

Authors/Readers/Third Parties can read, print and download, redistribute or republish the article (e.g. display in a repository), translate the article, download for text and data mining purposes, reuse portions or extracts from the article in other works, sell or re-use for commercial purposes, remix, transform, or build upon the material, they must distribute their contributions under the same license as the original Creative Commons Attribution-ShareAlike (CC BY-SA).